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Abstract: - Declared a pandemic in March of 2020, the coronavirus disease 2019 (COVID-19) infection took thousands of lives in 
the Philippines and over a million worldwide in less than a year. To alleviate the problem, diagnostic procedures must be performed 
in order to provide the patients’ appropriate treatment regimens. Aside from these diagnostic tools, other specific laboratory values 
can be used to monitor the patients’ condition and aid in their treatment. This research’s general objective, derived from these 
laboratory values, is to associate these laboratory values with the chosen levels of severity of the infection which are mild and severe, 
through the use of statistical analysis. To fulfill this objective, the formulated research problem seeks to answer the question: Which 
laboratory test value(s) will predict the severity of COVID-19 infection through statistical analysis called logistic regression. Specific 
attributes were chosen to determine the study participants, mild and severely infected COVID-19 infected inpatients of the chosen 
tertiary hospital in Manila given no comorbidities contracted prior to the infection. The study applied a census technique to acquire 
the best data set to evaluate the patient history and laboratory value received from the hospital. The data was interpreted with logistic 
regression to determine each laboratory value’s individual efficacy to the severity of infection. With respect to the generated outcome 
of results, the researchers arrived at the conclusion that seven out of the eight laboratory values namely neutrophils, lymphocytes, 
ALT, CRP, LDH, ferritin and d-dimer were significant predictors of the severity of COVID-19 infection. Procalcitonin was not 
considered significant. Recommendations for the clinical setting involve focusing on the increased biomarkers (neutrophils, ALT, 
CRP, LDH, ferritin, and d-dimer) and control the production of these biomarkers to prevent the adversary effects that may happen 
if the elevation is prolonged. Meanwhile, lymphocyte count was decreased, which means that treatments that can further suppress 
its production should not be administered.  
Key Words— COVID-19, Severity of Infection, Mild, Severe, Laboratory Values, Laboratory Parameters, Predictors, Logistic Regression.
I. INTRODUCTION 
Coronavirus disease 2019 (COVID-19), which is a newly 
discovered viral strain, is an infection caused by severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2) (Cennimo, 
2020). The infection originated in Wuhan, China and was 
reported back in December 2019. Few months after, the World 
Health Organization announced COVID-19 as a global  
 
 
pandemic which affects 123 countries worldwide (WHO, 
2020). 
Although the COVID-19 infection source has not been firmly 
established or determined, most evidence from reports suggests 
that it is a zoonotic disease with bats, pangolins, or seafood as 
possible hosts (WHO, 2020). Furthermore, the disease in 
humans is transmitted via direct contact and droplet infection 
when coughing or sneezing. According to several reports, 
symptomatic patients are the predominant transmission source 
(Ouassou et al. 2020). 
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The standard diagnostic procedure for the infection is Real-
Time Polymerase Chain Reaction (RT-PCR), which detects the 
genome of the virus in infected patients (FDA, 2020). Aside 
from the RT-PCR other specific laboratory tests are also done 
to monitor the patient’s condition and aid the treatment of the 
patients. These pertain to routine tests such as Complete Blood 
Count (CBC) for lymphocyte and neutrophil; tests for 
inflammation such as levels of C-reactive protein, ferritin, and 
procalcitonin; coagulation assay; and fibrinolysis process test 
like D-dimer; as well as serum alanine aminotransferase, and 
lactate dehydrogenase. 
The different classifications of severity for the COVID-19 
infection include mild, moderate, severe, and critical (WHO, 
2020). Mild diseases are found in patients who experience 
specific signs and symptoms such as fever, cough, fatigue, and 
nonspecific symptoms like headache, sore throat, and nasal 
congestion without findings of pneumonia or hypoxia. On the 
other hand, moderate diseases and severe diseases are 
associated with pneumonia and severe pneumonia. Lastly, 
critical diseases entail acute respiratory distress syndrome 
(ARDS) with a distinct clinical insult such as pneumonia or 
more aggravated respiratory symptoms. 
Given that the COVID-19 infection is still an ongoing 
pandemic, this study takes advantage of its timely, relevant, and 
indeterminate nature. Thus, to address the limited information 
known about the said disease, this study seeks to determine the 
relationship between the aforementioned laboratory test values 
and the disease severity classification. 
A. Statement of the Problem 
SARS-CoV-2, due to being a novel respiratory virus, has a 
distinct gap of studies in specific fields. There is explicitly a 
lack of literature that looks into the predictive capability of 
specific laboratory values to the severity of COVID-19 
infection. The few available either note the abnormal laboratory 
values of infected patients or only look into one or two 
particular values. This study is done to identify whether these 
laboratory values can predict COVID-19 infection severity 
between mild and severe infection: lymphocyte, neutrophil, 
serum alanine aminotransferase, lactate dehydrogenase, C-
reactive protein, ferritin, D-dimer, and procalcitonin. The 
following are the research problems: 
 How many COVID-19 cases are classified as mild or 
severe? 
 What are the results of the mentioned laboratory 
values in mild and severe COVID-19 infected 
patients? 
 What can significantly predict COVID-19 severity 
using the said laboratory values? 
B. Objectives of the Study 
Serving as the general objective of this study is the 
identification of the laboratory test values that will predict 
COVID-19 infection severity through the use of statistical 
analysis. Moreover, this study seeks to determine whether there 
is a significant difference–either increased or decreased–in the 
laboratory values of neutrophil, lymphocyte, ferritin, d-dimer, 
procalcitonin, lactate dehydrogenase, serum alanine 
aminotransferase, and c-reactive protein in the blood between 
COVID-19 positive patients classified as mild and severe. The 
study further aims to achieve the objectives that are aligned to 
address the following problems: 
 To determine the prevalence of COVID-19 cases 
classified as mild and severe; 
 To collate the results of the said laboratory values in 
mild and severe COVID-19 infected patients utilizing 
descriptive statistics; and 
 To determine which laboratory parameter can 
significantly predict the severity of COVID-19 
infection. 
C. Hypothesis of the Study 
These are the following hypotheses that will be tested to 
conclude the significance of laboratory test findings with the 
severity of COVID-19 infection: 
Ha: At least one of the following laboratory values such as 
lymphocyte, neutrophil, serum alanine 
aminotransferase, lactate dehydrogenase, C-reactive 
protein level, ferritin levels, D-dimer, or procalcitonin 
can significantly predict the severity of COVID-19 
infection. 
H0: The laboratory values such as lymphocyte, neutrophil, 
serum alanine aminotransferase, lactate 
dehydrogenase, C-reactive protein level, ferritin 
levels, D-dimer, and procalcitonin cannot significantly 
predict the severity of COVID-19 infection. 
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D. Research Impediments 
This study assessed the correlation of the specific laboratory 
values to the severity of infection. The chosen laboratory 
parameters were only limited to the prominent laboratory 
parameters reported by the article published in 2020 by the 
Center for Disease Control and Prevention (CDC) that was 
entitled, “Interim Clinical Guidance for Management of 
Patients with Confirmed Coronavirus Disease (COVID-19).” 
These laboratory parameters are neutrophils, lymphocytes, 
alanine aminotransferase, aspartate aminotransferase, c-
reactive protein, lactate dehydrogenase, ferritin, d-dimer, and 
procalcitonin. However, since the chosen hospital does not 
monitor the aspartate aminotransferase levels, the said 
parameter was excluded from the study. The study was also 
limited to mild and severe infections only, thus, patients under 
moderate and critical were excluded. Correlation of the 
laboratory values to the severity of infection was done to 
evaluate the clinical significance of the laboratory values to the 
severity of infection, and also with the intention of finding out 
which laboratory value has the most significant effect on the 
severity of infection.   
A number of 113 mildly and severely COVID-19 infected 
inpatients were chosen through a census technique due to 
limited data. The age range was from 18 - 59 years old and the 
majority of the patients had complete laboratory values. The 
patients were also tested and confirmed by RT-PCR and have 
no comorbidities prior to infection. Patients that presented 
insufficient or unnecessary information such as lacking half or 
more than half of the laboratory data, aging below 18 or above 
59, and not included in the mild or severe category, were taken 
out from the study. 
E. Significance of the Study 
The Philippines is one of the countries with the greatest 
numbers of recorded cases and deaths in the Western Pacific 
Region. Before the research for COVID-19 infection, its 
detection in mild and severe patients had already been 
considered in several studies. Despite this, there is still an 
absence of supporting studies that correlate with the 
aggravation of infection in COVID-19 patients. The result of 
this study will be of great benefit to the following: 
Researchers: Having satisfied the primary objective, which is 
to identify the significant laboratory test values that indicate the 
aggravating factors of the COVID-19 infection, this study 
benefits researchers to improve their comprehension of the 
COVID-19 infection. Moreover, researchers will be able to 
establish a link between this study and other similar studies 
done. 
Society: In analyzing the contributing laboratory results from 
mild and severe COVID-19 infected patients, the study will 
provide the public a better understanding by laying out further 
information and analysis regarding the aggravation of COVID-
19 infection. 
COVID-19 infected patients: This study is of great importance 
to all COVID-19 infected patients (from asymptomatic to 
critical cases) as this assists them in the overview of how the 
COVID-19 infection aggravates in their body. In addition, this 
can further help patients understand the effects of COVID-19 
infection in their laboratory findings. 
Medical personnel: Medical practitioners, particularly 
physicians and nurses, may utilize this study to further 
recognize the conditions of mild and severe COVID-19 infected 
patients by analyzing the statistical values made based on their 
significant laboratory findings. Moreover, this study leads more 
medical practitioners to perform effective treatment, 
management, and prevention of the COVID-19 infection. 
Future researchers: This study serves as a guide for the future 
researchers who aim to conduct further studies on the 
contributing laboratory values seen in COVID-19 infection 
cases. 
F. Definition of Terms 
The definition of terms provides the different significant 
terminologies that will be used throughout this study. 
Asymptomatic. Asymptomatic patients infected with a disease 
but do not show any clinical signs or symptoms. 
Biomarkers. Biomarkers refer to any value used as an indicator 
for the presence or absence of disease. These are associated 
with the laboratory values. 
Dependent variable. Dependent variables are the ones being 
tested in this research. They can vary according to the 
independent variables. 
Independent variable. Independent variables are constant and 
are the ones that can change the results of the dependent 
variables. 
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Laboratory abnormalities. Laboratory abnormalities refers to 
laboratory results that fall outside of the laboratory reference 
ranges. 
Laboratory values. Laboratory markers can be referred to as the 
laboratory parameters. They serve as the independent variables 
in this study. The values of the biomarkers to be measured are 
as follows: lymphocytes, neutrophils, serum alanine 
aminotransferase (ALT), lactate dehydrogenase (LDH), C-
reactive protein (CRP), ferritin, D-dimer, and procalcitonin 
(PCT). 
Logistic regression. Logistic regression is a statistical model 
that uses a set of independent variables to predict a categorical 
dependent variable. 
Mild. Mild infection refers to the symptomatic patients that 
have been established to have the COVID-19 infection but do 
not have viral pneumonia or hypoxia. 
Severe. Severe infection refers to the symptomatic patients that 
have been established to have the COVID-19 infection but has 
viral pneumonia or other pulmonary complications. 
Severity of infection. Severity of infection describes how ill the 
patient is. In this study, severity is in the form of mild and 
severe. It serves as the independent variables in this study that 
will entirely depend on the laboratory values or the independent 
variables. 
Statistical analysis. Statistical analysis is a term used to 
determine trends, patterns, and relationships between variables 
using quantitative data 
Symptomatic. Symptomatic patients infected with a disease that 
do show clinical signs or symptoms. 
II. REVIEW OF RELATED LITERATURE 
Today, the world is facing perhaps one of the most serious 
health issues to date: the coronavirus pandemic. The 
coronavirus disease, commonly known as COVID-19, is a 
highly transmissible infection brought about by the SARS-
CoV-2 virus. (Harapan et al., 2020) This new strain of 
coronavirus causes respiratory and extra-respiratory 
presentations that could be lethal depending on the severity of 
symptoms (Cascella et al., 2020). Coronavirus outbreaks have 
been recorded in the past years, including the Middle East 
respiratory syndrome (MERS) outbreak of 2014 and the severe 
acute respiratory syndrome (SARS) outbreak of 2003. 
However, this year’s pandemic involves a novel coronavirus 
later named the SARS-CoV-2, which will be discussed further 
in the succeeding paragraphs. 
A. SARS-CoV-2 
SARS-CoV-2 was first identified from a throat swab sample 
(Harapan et al. 2020). It was then identified in the respiratory 
tract of patients with pneumonia back in December 2019 in the 
same area. It was first indicated as a new β-coronavirus (nCoV) 
(Astuti & Ysrafil, 2020). It is the seventh of its kind that infects 
humans and the third in this classification capable of causing 
severe diseases together with SARS-CoV and MERS-CoV. It 
is a novel infectious respiratory virus that originated from 
Wuhan province, China (Han et al. 2020). Derived from bats, 
the virus was proven to be zoonotic in origin through 
transmission from pangolins to humans. Comparative genetic 
analysis indicates that SARS-CoV-2 exhibits closer similarities 
to others of the coronaviridae family, like SARS-CoVthan 
those of coronaviruses originating from pangolins (Li et al. 
2020). 
B. Classification & Viral Structure 
SARS-CoV-2 is identified as a single-stranded ribonucleic acid 
(RNA) virus consisting of 29,891 nucleotides that encodes 
around 9,860 amino acids. It often sports a pleomorphic form, 
can also be round or elliptic, and has a 60-140 nm diameter. The 
virus is classified under the Coronaviridae family, named after 
its crown-shaped morphology observed under an electron 
microscope and the genome, Betacoronavirus (Cascella et al., 
2020). The virus is composed of four major structural proteins: 
the spike (S) glycoprotein, nucleocapsid (N) protein, small 
envelope (E) glycoprotein, membrane (M) glycoprotein, and 
the. Firstly, the spike (S) protein is an outer transmembrane 
protein that creates homotrimers on the viral surface. With its 
attraction to the angiotensin-converting enzyme 2 (ACE2), this 
protein aids in the adhesion of the virus to the host cells. Second 
is the nucleocapsid (N) protein which is confined between the 
endoplasmic reticulum and the Golgi body regions. It is 
attached to the nucleic acid component of the virus and its 
binding process is a component of both the viral replication 
cycle and the cellular response of the host cell. Third is the 
small envelope (E) glycoprotein, the smallest protein among the 
four, which is involved in both the production and maturation 
of the virus. Lastly, the membrane (M) glycoprotein aids in 
determining the morphology of the virus. In addition, it 
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stabilizes the nucleocapsid protein which further helps 
complete the viral assembly. 
C.  Mode of Transmission 
Based on current evidence and studies, SARS-CoV-2 is 
transmitted by either humans and possibly bats as it is proven 
to be the reservoir of the virus. This transmission of the virus 
can be in the form of indirect contact with contaminated items 
or surfaces as well as with close contact with infected people 
through mouth and nose secretions. These secretions carrying 
the virus could be in the form of saliva or respiratory secretions 
and droplets, which can be expelled through sneezing or 
coughing. (WHO, 2020).  
Upon the virus’ entry into the body via infected droplets, it then 
enters various organs such as the heart, lungs, kidney, and 
gastrointestinal tract. The virus then adheres itself to the ACE2 
receptor of the host cells, which initiates the fusion of the virus 
and the human cell. Organs having the highest amount of ACE2 
receptors include the nasal epithelial cells of the respiratory 
tract. Once adhered, the virus will then deliver its genomic 
material, which would be further translated into proteins. A 
number of 14 open reading frames further encodes these 
proteins, which increases the virus’ virulence capability. The 
other proteins are further translated into accessory and 
structural proteins, which will then be isolated between the 
endoplasmic reticulum and the Golgi body of the host cell. 
Finally, these structural proteins will be combined with the 
nucleocapsids, forming small vesicles that would then be 
delivered outside the cell via exocytosis. As a result, this causes 
an irregular response to the antiviral T cell due to T cell 
apoptosis (Mohammadi et al., 2020). This eventually leads to 
decreased immune functioning and the development of the 
COVID-19 infection (Astuti & Ysrafil, 2020). 
D. Clinical Manifestations 
The most common clinical signs and symptoms associated 
upon admission with positive COVID-19 patients were fever, 
cough, and expectoration, according to a retrospective cohort 
study conducted by Yang et al. in Zheijang, China. In a total of 
149 patients examined from different hospitals, 114 (76.51%) 
patients had a fever, 87 (58.39%) had a cough, and 48 (32.21%) 
were expectorating. Dyspnea and vomiting were rare, only 
attributing to 2 (1.3%) patients each. As for further 
complications concerning the respiratory and excretory 
systems, none were detected, with the sole exception of mild 
pneumonia.  
Clinical characteristics observed in mild COVID-19 infected 
patients experience the following conditions: fever, respiratory 
related symptoms, CT features of viral pneumonia, and positive 
RT-PCR result (Liu et al. 2020). While severe COVID-19 
infected patients experience the following conditions: shortness 
of breath, a respiratory rate ≥30 breaths/minute, and a resting 
oxygen saturation ≤93%. Moreover, patients in a critical 
condition experience respiratory failure that requires the use of 
mechanical ventilation. Some critically ill patients are admitted 
to the intensive care unit (ICU) because of multiple organ 
dysfunction (Chen et al, 2020). 
Early clinical manifestations present in 87% of patients were 
pneumonia, 60% had a dry cough. In the CT scans of the 
patients, the lesions observed are referred to as ground-glass 
opacities (GGO’s). More than half of the cases that involved 
lesions present in two or more lobes of the lungs had the lesions 
located peripherally. Vascular thickening is also found in 80% 
of the cases (Han et al. 2020). 
E. Pathophysiology 
To address the underlying lack of information regarding the 
pathophysiology of COVID-19 infection, a study authored by 
Polak et al. (2020) established a timeline and correlation 
between histopathological findings and COVID-19 infection 
clinical stages by conducting a systematic review of published 
case reports and series. From the 198 individual cases and 42 
articles encompassing the study, the main pulmonary 
pathological findings were as follows: pneumonitis related to 
COVID-19 infection exhibited the same epithelial, vascular, 
and fibrotic patterns in lung injury. To further expound, 
changes in the epithelium were evident across all disease stages, 
vascular damages were detected, and characteristics of acute 
fibrinous and organizing pneumonia were identified in the early 
stages. Moreover, nonspecific pathological findings were also 
established in other tissue organs such as the heart, liver, 
kidneys, spleen, skin, placenta, lymph nodes, and 
gastrointestinal tract. It has been discovered that during the late 
stages of COVID-19 infection, the kidney, liver, and 
gastrointestinal tract harbors inflammatory infiltrates and 
epithelium damage. Likewise, microvascular injuries were also 
evident. 
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Currently, the main source of infection for COVID-19 is the 
patients themselves (Jin, 2020). Patients with severe cases of 
infection are far more contagious compared to those with mild 
cases. In addition, asymptomatic persons deemed as carriers of 
the disease and those in the incubation period are also 
considered potential sources of infection. The epidemiologic 
characteristic of COVID-19 infection can be attributed to a 
spatiotemporal kind of distribution. The disease source is 
Wuhan, China, and the start of the outbreak was in December 
2019. In terms of population distribution, the data from the 
CDC in China reported that the bracket for COVID-19 infected 
patients is mainly from 30-70 years of age. Four months into 
the outbreak, the World Health Organization (WHO) divulged 
data accounting for 190 countries that were already affected. As 
for the routes of transmission, respiratory droplets and direct 
contact are the main ways to pass on the disease. 
Due to SARS-CoV-2’s nature as a respiratory virus, droplet 
transmission allowed for the faster spread of infection. The 
disease was first presumed to be a nosocomial infection then 
determined to be a novel respiratory virus that caused acute 
respiratory distress syndrome along with other complications 
(Rothan & Byrareddy, 2020). The transmission was later traced 
back to a fish market in Wuhan province where the initial 
patients had visited. The disease shows a predilection for more 
severe infection for the older age groups and the 
immunocompromised. 
In the Philippine setting, the first suspected case of COVID-19 
infection was recorded in late January 2020 and was first 
detected from two Chinese nationals (hereby indicated as first 
and second patients). Among them, Patient 2, a 44-year-old 
male, was the first who exhibited symptoms such as fever back 
in Wuhan, China. Between the dates of January 20 and 25, they 
traveled from Wuhan to Hongkong and eventually reached 
several areas in the Philippines. Eventually, the first patient 
exhibited a manifestation of sore throat and dry cough. They 
were then sent to San Lazaro Hospital, and upon examination, 
the second patient was categorized under COVID-19 PUI 
(Person Under Investigation) and was isolated. The first patient 
was discharged in early February; however, the second patient 
further developed pneumonia. Despite treatments given to him, 
he succumbed to the disease and first confirmed death due to 
COVID-19 infection outside China. A third confirmed case was 
revealed early in February, also from a female Chinese national 
from Wuhan. Contact tracing was performed of the three 
confirmed patients. In addition to these, three hospital staff 
assigned to the given patients developed symptoms and were 
classified under PUI. 
G. Diagnosis 
In the Philippines, the most efficient way of detecting SARS-
CoV-2 infection is done using real-time polymerase chain 
reaction (RT-PCR). By far, the test is known to have the least 
amount of time and high specificity and sensitivity to detect the 
new coronavirus.  The procedure identifies the presence of the 
virus by converting its RNA into DNA through reverse 
transcription and DNA amplification. Specimens used to detect 
COVID-19 infection are nasopharyngeal swabs from possible 
patients (WHO, 2020). 
H. Laboratory Findings 
SARS-CoV-2 viral load (RNAemia) and Interleukin 6 (IL-6) 
levels in patients with COVID-19 were examined to determine 
the COVID-19 severity. In the study done by Chen et al., serum 
and throat swabs samples were obtained to determine IL-6 and 
viral RNA level of COVID-19 infected patients. It has been 
indicated in the study that COVID-19 is correlated to an 
elevated IL-6 in the plasma. Chen et al. suggested that Il-6 can 
serve as a biomarker for the severity of COVID-19 infection. 
The study showed that the IL-6 levels of critically ill COVID-
19 infected patients are higher in severe infections. High levels 
of IL-6 are said to be a useful driving force of cytokine storms 
that causes dysfunction in multiple organs of patients who are 
in critical condition. In addition, patients with RNAemia show 
higher IL-6 levels than other COVID-19 patients without 
RNAemia, which indicates that all patients with RNAemia have 
a higher risk of having multiple organ dysfunction (CHEN et 
al., 2020). 
To assess the immune status as well as the predictors that are 
associated with COVID-19 infection severity, He et al. (2020) 
conducted a study that was composed of 204 COVID-19 
positive patients with pneumonia. In the said study, the patients 
were divided into two groups which are as follows: patients that 
have severe COVID-19 infection with pneumonia and patients 
that are non-severe but have COVID-19 infection with 
pneumonia. Furthermore, a chest CT was performed on all of 
the patients in order to determine if there are any diagnosis for 
pneumonia in COVID-19 infection. In most of the patients with 
COVID-19 infection, the results of the chest CT have shown 
any indication of bilateral and multiple lobe lesions. The 
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laboratory results observed in the COVID-19 infection patients 
with pneumonia include median white blood cell count, platelet 
count, Lymphocyte, Urea, C-reactive protein, Neutrophil, 
Lactate dehydrogenase, D-dimer, and Aspartate 
aminotransferase. In addition, lymphocyte subsets were also 
counted such as B cell and NK cell (CD16+ 56+), CD8+ T cell, 
CD4+ T cell, as well as CD3+ T cell. Based on the study, the 
lymphocyte subsets count observed in severe patients is 
significantly lower compared to the lymphocyte subsets count 
of non-severe patients. In the humoral immune function, high 
IgG, Complement C3, and low IgM were observed in severe 
patients. 
Furthermore, the observations in Interleukin 4 (IL-4) and TNF-
α are higher in severe patients than non-severe patients. In 
contrast, the results conducted by He et al. (2020) indicate that 
the levels of IL-4, TNF-α, IgG, and C3 are negatively correlated 
with the T cell counts in severe patients with COVID-19 
infection pneumonia. In contrast, IgM has shown a positive 
correlation with the T cell count in severe patients with 
COVID-19 infection pneumonia. 
Significant laboratory findings in the patients include 
leucopenia with decreased leukocyte counts that are more 
prominent in severe cases (Gao et al. 2020) (Rothan & 
Byrareddy, 2020). Other Blood Cells also experience a 
significant decrease in severe infections like the eosinophils and 
platelets (Liao et al. 2020). Liao et al. mention how D-dimer 
and fibrin degradation products (FDP) were substantially 
higher in more severely infected cases (2020). In concurrence 
with the former, fibrinogen concentrations were significantly 
decreased in more afflicted patients. An increase in CRP levels 
above the normal range was noted by Rothan & Byrareddy 
(2020). 
I. Other Similar Studies 
The Usage of Logistic Regression on the Severity of Infection: 
Liu et al. (2020) decided to address the risk assessment for 
clinical management in Renmin Hospital of Wuhan University 
due to the report of the WHO that the number of COVID-19 
infected patients challenged the frontline clinical staff. A total 
of 99 patients with moderate and severe COVID-19 infections 
were used as the sample population: 61 non-severe patients and 
38 severe patients. The instruments used were: demographic 
data, clinical data, laboratory findings, and treatment data. The 
severity of infection and the length of hospital stay were 
investigated using specific statistical methods to derive the risk 
factors that affect these variables. For the severity of infection, 
statistical analysis such as multivariate and univariate logistic 
regression were both used. Laboratory findings such as 
lymphopenia, elevated neutrophil count, LDH, increased CRP, 
and specific symptoms including dyspnea, fatigue, and 
anorexia or lethargy were associated with severe COVID-19 
infection cases. 
Moreover, to evaluate the tendency of long or short hospital 
stays, Spearman’s correlation technique was used to associate 
the findings and the number of stays in the hospital. With this, 
it was discovered that the length of hospital stay is prolonged in 
COVID-19 infected patients with lymphopenia. Using 
statistical analysis, logistic regression, this study showed 
accuracy in associating the laboratory findings and the severity 
of infection. This study perfectly utilized these variables to 
show the role of the laboratory values in the causation of the 
severity of infection. Spearman’s correlation technique was 
also used for the length of hospital stay, but that is out of the 
scope of this research already, so it will not be explored further. 
All in all, the study by Liu et al. and this research are both quite 
similar. The difference is that this research aims to have an 
equal amount of the mild and severe population as much as 
possible. If not equal, the gap should not be as big as 61 and 38 
since there will be much more accuracy if the two populations 
were equal or near equal. Having a much smaller amount for 
either of the population might not be enough to say that that 
amount of population applies to everyone. 
The Usage of Central Tendency on the Severity of Infection: 
The study conducted by Fan et al. (2020) examined the atypical 
hematological parameters found in COVID-19 infected 
patients. Common findings in COVID-19 infected patients 
were Leukopenia and Lymphopenia. ICU bound subjects also 
had LDH levels higher than the peak LDH levels of non-ICU 
subjects. During their stay in the hospital, patients developed 
neutrophilia. Certain limitations in the study were that certain 
laboratory tests had not been performed on all the subjects of 
the study. The LDH values were taken only in a subset of the 
total patients making the data slightly biased. The subjects of 
the study also make it so that the values derived from it are 
somewhat unreliable in terms of the comparison of values 
between mild and severely infected patients due to the larger 
population of 58 non-ICU patients compared to the 9 ICU 
patients. The data gathered in the study does reflect similar 
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values to other analogous studies. However, the statistical 
analysis applied to the study shows a very shallow 
understanding of the data gathered due to Fan et al. (2020) 
usage of central tendency to show a correlation in some of the 
values. The usage of other more statistically significant 
methods such as linear regression or logistic regression for 
more reliable data analysis and quantitation. 
Meta-Analytic Study on the Laboratory Findings of COVID-19 
Infected Patients: 
A total of 19 articles were laid out from the study of 
Pourbagheri-Sigaroodi, et al. (2020) that suggest a 
comprehensive analysis of the laboratory findings of COVID-
19 infected patients. The documented laboratory findings were 
correlated with the diagnosis and prognosis of COVID-19 
infected patients. Pourbagheri-Sigaroodi et al. (2020) analyzed 
the complete blood count, PT, aPTT, D-dimers, erythrocyte 
sedimentation rate (ESR), CRP, PCT and biochemical factors 
of COVID-19 infected patients to evaluate how the 
aforementioned laboratory findings were affected in the 
aggravation of COVID-19 infection. In relation, the diagnostic 
values reported showed that the leukocytes and neutrophils are 
significantly higher in the complete blood count of severe 
COVID-19 infected patients as compared to non-severe 
COVID-19 infected patients. The gathered diagnostic results 
from the published articles were summarized and examined 
through meta-analysis. To conclude, the study of Pourbagheri-
Sigaroodi et al. (2020) correlated the frequency of lymphocytes, 
leukocytes and, neutrophils in the severe patients and non-
severe patients, concluding that the elevated neutrophil-to-
lymphocyte ratio (NLR) could predict prognosis for COVID-
19 infected patients.  Although in this study of Pourbagheri-
Sigaroodi et al. (2020) it must be noted that using frequency 
alone provides insufficient data to generate a well-supported 
and comprehensive analysis on the correlation of the laboratory 
findings from patients with COVID-19 infection. Moreover, the 
values Pourbagheri-Sigaroodi et al. used in the study were only 
gathered from the published articles that have been selected by 
the researchers, which have failed to establish accuracy on 
uncontrollable data. 
J. Theoretical Study 
Laboratory Findings: 
The primary basis of this study is the article published in 2020 
by the Center for Disease Control and Prevention (CDC) that 
was entitled, “Interim Clinical Guidance for Management of 
Patients with Confirmed Coronavirus Disease (COVID-19).” 
According to their findings, the anomalous laboratory values 
prevalent in patients infected with COVID-19 include: 
lymphopenia, neutrophilia, elevated serum alanine 
aminotransferase (ALT) and AST levels, elevated LDH, high 
CRP, high ferritin levels, elevated D-dimer, and increased PCT. 
These biomarkers serve as the independent variables used in 
this study. Aside from the paper of CDC, other related studies 
by various researchers were used to corroborate and reinforce 
the contents of the paper. 
a. Increased Ferritin, ESR, ALT, and D-Dimer Levels: 
Chowdhurry et al. (2020) also conducted a study that was able 
to garner the results of increased values of CRP and 
Prothrombin time in all patients. The other laboratory values 
such as ferritin, ESR, ALT, and D-Dimer levels were also 
shown to be elevated in most of the patients. Some presented 
with lymphocytopenia, while several presented with mild 
erythrocytopenia. Their study deduced that the possible usage 
of CRP, Prothrombin time, serum ferritin, ESR, ALT, D-
Dimer, erythrocytopenia and lymphocytopenia as a diagnosis 
for initial hematological findings also has the capability for 
COVID-19 infection prognosis.  
A different study conducted by Pizzi et al. (2020), also elicited 
that patients infected with COVID-19 showed a significant 
increase in CRP, LDH and ferritin levels in comparison to non-
COVID-19 infected patients. 
b. High C-reactive Protein: 
Zhu et al. (2020) evaluated patients with COVID-19 infection 
that had increased amounts of IL-6, CRP and hypertension. 
These abnormal values were found to be independent predictors 
for COVID-19 infection severity. These three laboratory values 
were elaborated to exhibit the highest correlation to the severity 
of infection.  
Furthermore, the findings regarding the results of other 
laboratory values such as notable increase of NLR, fibrinogen, 
sialic acid, IL-10, and IFN-γ in patients with severe COVID-19 
infection in comparison to patients with non-severe COVID-19 
infection were also shown. On the other hand, the value of 
lymphocyte levels and platelets were remarkably lower in 
patients with severe COVID-19 infection than in patients with 
non-severe COVID-19 infection. 
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Li et al. (2020) analyzed that neutrophilia and elevated 
ultrasensitive cardiac troponin I were both independently 
associated with COVID-19 infected patient death. These 
findings were also more oriented toward elderly patients than 
younger patients. 
d. Elevated D-Dimer: 
The main focus of a study by Zhang et al is the elevation of D-
dimer levels of patients diagnosed with COVID-19 infection. 
In the study, it was discovered that the D-dimer level of the 
patients is greater than 2.0 μg/mL upon their admission and is 
an effective independent predictor for mortality of in-patients 
with COVID-19. Out of 343 patients examined, 67 patients had 
a ≥ 2.0 μg/mL upon admission, meanwhile, 267 patients had a 
< 2.0 μg/mL of D-dimer level upon admission. During their stay 
in the hospital, a total of 13 patients died from the disease. The 
patients with D-mer levels that are lower than 2.0 μg/mL upon 
admission attributed to an increased mortality rate than of the 
patients with a greater than or equal to 2.0  μg/mL D-dimer level 
upon admission. The probable reasons theorized were that viral 
infections induce inflammatory response that cause the 
endothelial cells to over function thus increasing thrombin 
synthesis; severe COVID-19 infection causes hypoxia which 
stimulates thrombosis; COVID-19 infected patients of the older 
age are predisposed to certain conditions that are considered 
risk factors for thrombosis; some cases may cause sepsis-
induced coagulopathy or disseminated intravascular 
coagulation which are unfavorable situations that may elevate 
D-dimer levels. 
Increased Ferritin, and PCT Levels: 
Ferritin is a protein that is composed of 24 H- and L-subunits 
which are present in the body fluids of a person, specifically in 
blood plasma and serum (Wang et al. 2010). Prior to assessment 
of disease severity, Kappert, Jahic & Tauber. (2020) analyzed 
the immunological and laboratory characteristics of 21 
COVID-19 infected patients. All patients were classified as 
severe and moderate cases. Among the 21 patients, 12 patients 
presented a remarkably increased serum ferritin value. In 
addition, other inflammatory biomarkers were observed in 
patients which include high-sensitive CRP, IL-6, and PCT. 
These markers are significantly higher in severe cases than 
moderate cases. In this case, Kappert et al. suggests that the 
high level of systemic inflammation and high level of 
inflammatory biomarkers demonstrated in patients, correlates 
with the severity of the disease. The documented laboratory 
serum ferritin in several COVID-19 infection studies indicates 
that ferritin can be used as a biomarker in assessing the severity 
of COVID-19 infection in hospitalized patients. 
Classification of the Severity of Infection: 
a. Classification of Mild and Severe Infections by CDC: 
The CDC (2020) has established its own classification of the 
severity of infection for the COVID-19 infected patients. The 
COVID-19 infected patients have been classified into three: 
Mild to moderate, severe, and critical. However, only the 
classifications mild to moderate and severe will be tackled.  
Mild to moderate clinical presentations exclude the presence of 
viral pneumonia and hypoxia. This level of severity does not 
initially require hospitalization and can be managed at home. 
The decision for hospitalization depends on the clinical 
presentation, supportive care requirement, potential risk factors 
for severe disease, and how the person can self-isolate at home. 
Severe clinical presentations include the presence of 
pneumonia, hypoxemic respiratory failure or acute respiratory 
distress syndrome (ARDS), sepsis, cardiomyopathy, and acute 
kidney injury. This level of severity requires hospitalization for 
proper care and treatment. There are some scenarios wherein 
long periods of hospitalization account for the severity of 
infection due to the acquired complications. These 
complications are as follows: secondary bacterial infections, 
thromboembolism, gastrointestinal bleeding, and critical illness 
neuropathy or myopathy. 
b. Classification of Mild and Severe Infections by WHO: 
The severity of COVID-19 infection has several classifications 
as per the official published Interim Guidelines for its clinical 
management issued by WHO in 2020. COVID-19 infection 
severity can be categorized as mild, moderate, severe, and 
critical.  
Mild diseases are associated with symptomatic patients who 
present classic signs and symptoms such as fever, cough, 
fatigue, and shortness of breath, along with other nonspecific 
symptoms like headache, nasal congestion, and sore throat; 
however, there is no clinical manifestation of viral pneumonia 
or hypoxia. 
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On the other hand, diseases that are classified as moderate are 
common in adults and adolescents with clinical manifestations 
of pneumonia (excluding the presentations in severe cases of 
pneumonia) such as cough, fever, and hyperpnea. Similarly, 
children with moderate diseases express difficulty in breathing, 
rapid breaths, and cough which are signs of pneumonia that is 
categorized as non-severe. 
Severe diseases are accompanied by severe pneumonia. In 
adolescents and adults, clinical signs of pneumonia are 
manifested with the addition of severe respiratory distress. 
Meanwhile, children with severe disease exhibit signs of 
pneumonia along with at least one of the other manifestations 
such as severe respiratory distress, central cyanosis, and general 
danger signs— convulsions, lethargy, inability to breastfeed or 
drink. 
Critical diseases are associated with several conditions like 
ARDS, septic shock, and sepsis. The aforementioned disease 
manifestations pose a serious threat to life. 
c. Classification of Mild and Severe Infections in 
association with Laboratory Diagnosis: 
A study of Bhargava et al. (2020) evaluated the severity of 
COVID-19 infection by analyzing the laboratory findings and 
clinical parameters including vital signs, presenting symptoms, 
presence of comorbid condition, and status on intubation and 
intensive care unit admission of 197 hospitalized COVID-19 
infected patients.  
In this study, patients with mild COVID-19 infection frequently 
demonstrated a presence of sore throat and cough. Moreover, 
severe infection is shown to be caused by an increase in 
inflammatory response, white blood cell counts, CRP levels, 
and PCT level. However, it demonstrated a low lymphocyte and 
platelet counts compared with patients with mild COVID-19 
infection. The gathered results indicate that patients aged 60 
years and older are more expected to have a severe COVID-19 
infection, which would require intubation and admission to the 
intensive care unit compared with patients with mild infection. 
Patients with severe COVID-19 infection are also more 
susceptible to have at least one comorbid condition, 
significantly like diabetes, renal disease, and chronic 
pulmonary diseases. Additionally, severely infected patients 
are expected to be tachypneic, which would lead to low oxygen 
saturation during the time of hospital admittance. 
Clinical Statistical Tool: 
a. An Overview of Logistic Regression: 
Logistic regression is commonly utilized in the clinical setting 
by estimating whether there will be a presence or an absence of 
a symptom or an increase or decrease of a variable in the 
connection to an independent variable. It usually studies the 
past clinical manifestations of patients in estimating the odds of 
a result by mathematically simulating those manifestations and 
describing it through a regression equation. In this way, a 
relationship between a dependent variable like age, symptoms, 
or routine laboratory test values and an independent variable 
like a presence or absence, or the severeness (either acute or 
chronic) of a disease (Anderson, et. al., 2003). 
b. Logistic Regression Analysis of Clinical Laboratory 
Data to Determine Patients with Severe COVID-19 
Infection: 
In a study conducted by Gao et al., the researchers aim to 
identify for warning indices present in severe COVID-19 
infected patients using laboratory data such as alanine 
aminotransferase (ALT), glucose (GLU), interleukin-6 (IL-6), 
procalcitonin (PCT), and D-dimer (D-D) levels. Initially, the 
given data were not normally distributed but eventually were 
further compared between two groups using the Mann-Whitney 
U tests. The subsequent results were then shown using the 
interquartile range. The logistic regression, the confidence 
interval of the receiver operator curve, and the area under the 
curve (AUC) were then computed using the predicted 
probability of severe COVID-19 infection and were further 
analyzed using the SPSS software. The prediction of the disease 
severity was determined with the use of Youden’s index. From 
the analysis, the researchers were able to deduce that IL-6 and 
D-D levels are possible parameters which can be used to 
estimate COVID-19 infection severity. This proves that the 
following parameters can be measured in order to diagnose the 
severity. 
c. The Usage of Logistic Regression on Mortality Rate of 
the Severity of Infection: 
In the study conducted by Liao et. al. (2020), logistic regression 
was applied as the statistical analysis. This functions to evaluate 
the chosen independent variables and the effects on the 
mortality of severely and critically infected COVID-19 
patients. The variables determined were select hematologic 
parameters such as D-dimer, Prothrombin Time, activated 
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partial thromboplastin time (aPTT) etc. that were determined to 
have some effect on patient mortality. The binomial dependent 
variable in this case is the severe and critical classification 
which is related statistically to the independent hematologic 
variables through use of logistic regression. The logistic 
regression establishes a relationship and degree of effect similar 
to multiple linear regression, by use of the odds ratio of each 
independent variable in relation to the target event, which is the 
binomial dependent variable (Sperandei, 2014). 
K. Conceptual Framework 
The paradigm of the study will be as follows: 
Fig.1. Conceptual Framework 
The paradigm of the study was based on the research done by 
Shanget al. (2020), wherein they collated laboratory data of 
COVID-19 infected patients from Wuhan Forth Hospital.  
Medical records and laboratory results of the said patients were 
gathered. The values for leukocyte, neutrophils, lymphocytes, 
NLR, hemoglobin, platelets, D‐dimer, ESR, CRP, PCT, LDH, 
uric acid, creatinine, and albumin results were analyzed 
statistically to find out the connection of the values to the 
severity of COVID-19 infection.  
The study will apply a similar approach to that done by Shang 
et al. (2020) and in which the concepts of the research are 
shown in the framework above. The given framework shows 
the flow of the concepts and the relationships between the study 
variables, which aims to interpret laboratory findings to the 
severity of COVID-19 infection. The independent variables 
given include the results, which are requested from the hospital 
from infected COVID-19 inpatients using eight laboratory 
values. These values will then be analyzed through the 
intermediate variables, which are the logistical regression 
statistical treatment and the purposive sampling. Lastly, the 
dependent variable is the final interpretation of the values and 
parameters that could predict the COVID-19 infection severity 
as either mild or severe. 
III. RESEARCH METHODS 
This chapter outlines the methods utilized in the study. Firstly, 
the research design illustrates the methods and framework 
required to address the research question. Following are the 
target participants, which were identified by the sampling 
technique, the inclusion and exclusion criteria, and any relevant 
rationale for the decisions made. Next, the data gathering and 
handling methods applied to ensure proponent safety and 
patient confidentiality–and finally, the statistical treatments and 
analysis applied on the data. 
A. Research Design 
A quantitative research design was employed by the researchers 
in conducting the study. Quantitative research, according to 
Steber (2017), emphasizes the numerical analysis of data 
collected in response to relational inquiry of variables within 
the research. In addition, the study also utilized an analytic 
retrospective research design. This is due to the fact that the 
study aims to determine the relationship of several variables 
with specific target variables. The relationship established is 
then used to predict a corresponding outcome. By definition, 
analytical studies assess the hypothesis by using the variables 
in order to create causal relationships (Ranganathan & 
Aggarwal, 2018). Meanwhile, included under the types of 
analytical studies is the retrospective approach which pertains 
to the specific time of conducting the research with respect to 
the observation of results. In a retrospective study, the outcome 
has already happened and the data is acquired from records 
(Parab & Bhalerao, 2010).  
 
In particular, this study made use of correlation analysis that 
utilizes logistic regression. Correlation analysis determines 
whether the significant routine laboratory values are associated 
with the severity of the COVID-19 infection. Logistic 
regression model has a fixed number of parameters that are 
dependent on the number of input variables, which output as a 
categorical predictor (Hoffman, 2019).  
 
In this study, clinically significant routine laboratory values 
from the secondary data of COVID-19 infected patients were 
obtained from the chosen tertiary hospital in Manila. This set of 
data is the laboratory values such as lymphocyte count, 
neutrophil count, serum alanine aminotransferase level, lactate 
dehydrogenase level, C-reactive protein level, ferritin level, D-
dimer level, and procalcitonin level will be used as variables in 
INTERNATIONAL JOURNAL OF PROGRESSIVE RESEARCH IN SCIENCE AND ENGINEERING, VOL.2, NO.7, JULY 2021. 
 
  
JOSEPHINE JOY C. CANAYON., et.al: ANALYSIS OF MAJOR LABORATORY TEST RESULT ABNORMALITIES IN MILD 
AND SEVERE COVID-19 INFECTIONS 
158 
 
determining the major contributory laboratory abnormalities in 
patients with mild and severe COVID-19 infection. 
B. Participants 
Sampling Technique: 
The sample population in this study is considered as 
heterogenous in which the census technique was used. As 
opposed to a sampling technique where only a fraction of the 
population that matched the criteria is studied, census technique 
involves studying each and every unit of the population that is 
suitable for the study (Mertinez-Mesa et al., 2016). Thus, by 
analyzing the entirety of the population, it makes the analysis 
more accurate and reliable compared to sampling technique. In 
addition, the population does not contain a margin of error since 
the entire population was selected that matched the given 
criteria. 
 
Due to the limited available data for this study, the researchers 
chose to include all eligible records totalling to 113 patients 
records. There are specifically 58 patients from the mild cases 
and 55 patients from the severe cases who were confined in the 
chosen tertiary hospital in Manila from March 2020 to January 
2021. Since the entirety of the population of interest is being 
studied, sampling techniques are no more applicable in this 
case. Thus, a computation for the sample size would not be 
provided. 
 
There was no manner of recruitment since the information was 
based on the secondary data obtained from the clinical 
laboratory in the chosen tertiary hospital in Manila. 
Inclusion Criteria: 
The general focus and purpose of this study is to use statistical 
analysis on various laboratory parameters as predictors of 
COVID-19 infection. Eight parameters will be analyzed 
including lymphocytes, neutrophils, ALT, LDH, CRP, ferritin, 
D-dimer, and PCT. 
 
This study made use of secondary data, which were derived 
from the laboratory records of inpatients with confirmed 
COVID-19 infection, validated through RT-PCR test, and are 
either classified as mild or severe infection by the chosen 
hospital. The data summed up a total of 113 patients.  
 
As for the patient profile, patients of both genders with ages 
ranging from 18-59 years old, with the aforementioned 
laboratory parameters on record, are included. The data were 
segregated according to the infection severity which was 
assigned by the hospital. The medical record stating the 
patient’s severity of infection was only asked if the hospital 
failed to categorize the patients’ condition whether mild or 
severe infection in the patients’ laboratory results. 
Exclusion Criteria: 
Patients that lack half or more than half of the laboratory data 
were excluded from the study. In addition, all patients with 
existing disease or comorbidity prior to COVID-19 infection 
were also not included. The patient admission status must only 
be ‘inpatient’, thus, outpatients are excluded in the study. 
 
To ensure that all data collected meets the desired parameters 
set by the researchers in the inclusion criteria, a thorough 
manual data review was done to ascertain that the right data 
were excluded for the study.  All excluded data were removed 
from the samples to be statistically analysed and were deleted 
permanently from all devices. 
Withdrawal Criteria: 
Due to the nature of the study, there are no direct individual 
participants involved but rather only collated data previously 
collected by the hospital that were used for patient diagnosis 
and care. Therefore, there are no withdrawal criteria for safety 
concerns regarding human participants in an experimental 
study. The only withdrawal criteria applicable would be if the 
hospital rescinds approval to conduct study with the hospital’s 
data and prohibits the publishing of the data acquired. 
Suitability of Study Site: 
The suitability of the site must be determined in order to ensure 
that the information acquired from the said source is factual and 
relevant to the topic of interest (LibreTexts, 2019). It is 
important to consider a site or source that can directly address 
or sufficiently contribute in answering the research problems 
and objectives. 
 
The hospital chosen is classified as a tertiary hospital and with 
a fully operating laboratory information system (LIS) to ensure 
that the data could be procured digitally. 
 
The researchers went to the hospital to personally gain access 
to the medical records and results. Data collected from the 
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tertiary hospital were manually checked and it was ensured that 
it fulfills the required criteria set forth by the researchers. All 
medical laboratory data of the patients included in the study 
were organized on a spreadsheet for proper organization and 
were statistically treated as mentioned on the data analysis 
section of the paper.  
C. Data Measure/Instrumentation 
The data used in this research are secondary data requested 
from a tertiary hospital. This research studied the laboratory 
values of patients with mild and severe COVID-19 infection. 
Therefore, the chosen hospital wherein the values were 
acquired was a COVID-19 infection referral hospital, which 
admits patients with the aforementioned disease. Furthermore, 
since the laboratory values included in this study are 
lymphocyte count, neutrophil count, serum alanine 
aminotransferase, ferritin, C-reactive protein, D-dimer, lactate 
dehydrogenase, and procalcitonin, the chosen hospital was 
made sure to be able to accommodate the required parameters. 
The chosen tertiary hospital was located in the Philippines. 
Moreover, the chosen tertiary hospital already identified the 
classification of severity–mild or severe–and distinguished the 
patients of COVID-19 infection with co-morbidities. 
All secondary data came from the values derived from the 
patients’ laboratory records confined in the hospital. 
Laboratory test values came from the subjects’ complete blood 
count tests (lymphocytes and neutrophils), assays for 
coagulation and fibrinolysis cascades (D-dimers), biochemical 
tests (lactate dehydrogenase), ALT tests (serum alanine 
aminotransferase), and inflammation-related parameters (CRP, 
ferritin, and PCT).  
 
Table.1. Reference Ranges of the Laboratory Values 
(Dependent Variables) 
Laboratory Parameters  Reference Range  Unit of 
Measurement 
Neutrophils 0.55 - 0.70 U/L1 
Lymphocytes 0.25 - 0.40 U/L 
Serum Alanine 
Aminotransferase 
14 - 54 U/L 
Lactate dehydrogenase 135 - 225 U/L 
C-reactive protein 0 - 5 mg/L2 
Ferritin 12 - 336 mg/L 
D-Dimer < 0.5 ug/mL3 
Procalcitonin 0.5 - 2 ng/mL4 
Note: Reference values were taken from the laboratory where the data 
was acquired. 
1 U/L means units per liter 
2 mg/L means milligram per liter 
3 ug/mL means microgram per milliliter 
4ng/mL means nanogram per milliliter 
 
The table shows the eight laboratory values that act as the 
dependent variables in this study. Each laboratory parameter 
has its own reference range, which is considered normal; and it 
should be noted that any value not within the respective 
reference range is considered either increased or decreased. The 
laboratory parameters are as follows: 
 
Complete Blood Count: 
Neutrophils are a type of white blood cell that arises in certain 
conditions such as infections, injuries or other types of stress 
because it heals damaged tissues and resolves infections 
(Huizen, 2020). The neutrophil count should be within the 
reference range of 0.55 to 0.70 U/L. 
 
Lymphocytes are also a type of white blood cell considered to 
be one of the body’s main types of immune cells. There are two 
types of lymphocytes: (1) B-cells function mainly for immunity 
wherein recurring infections are quickly eliminated, and (2) T-
cells kill pathogens that neutrophils are not capable of 
eliminating (Silva, 2020). The lymphocyte count should be 
within the reference range of 0.25 to 0.40 U/L. 
 
ALT Test: 
ALT is an enzyme that is found in many tissues and 
predominantly has high concentrations in the liver. Thus, it 
used to diagnose liver diseases (Bishop, 2017). Normal ALT 
levels range from 14 - 54 U/L. 
 
Biochemical Test: 
LDH is an enzyme that turns sugar into energy. Its activity is 
increased when the enzyme is released from ruptured red blood 
cells (Keohane, et. al, 2020). The normal level of LDH is 135 - 
225 units per liter. 
 
Assay for Coagulation and Fibrinolysis Cascades: 
D-Dimer in the bloodstream indicates current or recent 
coagulation and subsequent fibrinolysis. As a result, D-Dimer 
serves as an indirect coagulation and fibrinolysis marker 
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(Bishop, 2020). The normal value of D-Dimer is < 0.5 
micrograms per milliliter. 
 
Inflammation-Related Parameters: 
Ferritin is a protein that stores iron and functions within the 
cells. Ferritin levels indicate the amount of iron that is stored in 
the body and has a normal range of 12 - 336 mg/L (Keohane, 
et. al, 2020).  
 
CRP is an inflammatory marker found in the bloodstream, 
produced by the liver. The C-reactive protein test measures the 
concentration of CRP present in the blood which helps diagnose 
chronic and acute inflammatory conditions (Huizen, 2018). 
 
PCT is commonly produced in reaction to bacterial infections 
but it can also be produced in response to tissue injury. 
Identification of septic patients with this laboratory parameter 
has a higher specificity compared to other proinflammatory 
markers (Jin & Khan, 2010). The normal value of PCT is 0.5 - 
2 nanograms per milliliter. 
 
The instruments utilized in this study includes the patients’ 
information that were admitted from March 1, 2020 up to 
January 6, 2020. The idea behind this date is that around March 
was the time when the COVID-19 cases in the Philippines 
started to surge up again (Roser, et al. 2020). Moreover, the 
Philippine government announced a state of calamity in the 
country and declared “community quarantine” for Metro 
Manila in March 2020 (Duddu, 2020). Any data after January 
6, 2021 is excluded from the study. This is to prevent the 
utilization of the new strain of the COVID-19 infection that 
emerged in December 2020 (WHO, 2020) that was only 
reported in the Philippines on January 7, 2021 (DOH, 2021). 
D. Data Gathering Procedure 
The laboratory test results from the mild and severe COVID-19 
infected patients were acquired from the chosen hospital. The 
secondary data was requested specifically from the hospital 
administrators. With this, a letter of request was sent to the 
hospital outlining a summary of the study and its future 
applications, as well as a list of all the laboratory values needed 
for the study. The said data were gathered along with a letter of 
consent, in which the administrators will grant their approval. 
Since the researchers do not have any contact with the patients, 
the consent and approval came from the hospital administrators 
themselves. 
This documentation warrants that the data to be presented in 
this research are valid. The researchers directly went to the 
hospital itself to provide the hospital administrator with the 
letter that requests for the pertinent data together with the 
consent of approval. After acquiring the hospital’s approval, 
researchers went to the hospital to collect the data personally 
due to the administrator's preference regarding data security. 
The data was handled with extreme caution regarding patient 
privacy and prevented any leakage of patient information. All 
the records were uploaded to the master data file in software 
like Microsoft Excel and was further analyzed. 
 
 
Fig.2. Procedural Flowchart 
E. Ethical Considerations 
To address and minimize the possible risks associated with this 
study, the researchers will also abide by the established 
guidelines of the World Medical Association’s Declaration of 
Helsinki, which consists of statements of ethical principles for 
medical research that involves human subjects and also 
researches on identifiable human material and data; and it 
mainly serves physicians but is applicable to all medical 
researches involving any human subjects or data (World 
Medical Association, 2013). Since the study involves the 
analysis of laboratory values, as well as possibly medical 
records, it is mandatory to submit to the governing principles of 
the said declaration. 
 
The principles used to further elaborate the ethical 
considerations are from the World Medical Association’s 
Declaration of Helsinki in 2013: 
 
● In compliance with the 22nd principle under 
“Scientific Requirements and Research Protocols”, 
the ethical considerations have been included and 
clearly explained in the chapter. Dedicated sections 
are also provided in the succeeding parts of this paper 
to further expound on the conflict of interests, and 
incentives or compensation. 
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● As for the 23rd principle under “Research Ethics 
Committees” and 32nd principle under “Informed 
Consent,” necessary forms were filled out and 
submitted to the UST Faculty of Pharmacy Research 
Ethics Committee (FOPREC) for evaluation and 
approval. The researchers were also required to allow 
FOPREC to monitor the study, as well as to submit a 
final report including the summary of findings and 
conclusions of the study. 
● In response to the 7th, 8th, and 9th principles under 
“General Principles”; and 24th principle under 
“Privacy and Confidentiality,” the ethical 
considerations addressed are confidentiality and 
anonymity. The method in which the researchers 
gathered information was in accordance with Republic 
Act No. 10173 also known as the “Data Privacy Act 
of 2012” and the Health Privacy Code Administrative 
Order No. 2016-00022 “Privacy Guidelines for the 
Implementation of the Philippine Health Information 
Exchange”. The Data Privacy Act of 2012 the law that 
protects individual personal information stored in 
information systems in both government and private 
organizations. Furthermore, Section 2 of the Data 
Privacy Act of 2012 states that, “the State recognizes 
the vital role of information and communications 
technology in nation-building and its inherent 
obligation to ensure that personal information in 
information and communications systems in the 
government and in the private sector are secured and 
protected.”. As for the Health Privacy Code 
Administrative Order No. 2016-00022, this 
specifically implements the aforementioned republic 
act in exchanging health information. The Health 
Privacy Code Administrative Order No. 2016-00022 
was integrated in the study and served as the main 
guideline to protect the confidentiality of the patients 
afflicted with COVID-19 infection. The researchers 
selected a tertiary hospital laboratory in which the data 
were collected, however, the name of the hospital was 
stated in the entire study. Afterward, consent was 
obtained from a duly authorized staff. As such, the 
consent was received from a social worker or an 
attending physician (Rule 1, Section 1.3). 
Furthermore, as per Rule 10, Section 4, subsection D, 
the medical records to be acquired must be subjected 
to technical anonymization procedures and must be 
declared clear for public access by a duly constituted 
ethics committee. To ensure a systematic 
classification, the anonymization procedure employed 
is the assignment of a numerical code to the patient 
(e.g. Patient 1, Patient 2). The data were stored in a 
flash drive to secure data privacy. Access to the data 
was restricted only to the researchers and the 
statistician who shall use the data only within the time 
period of the research proper, which is from August 
2020 to May 2021. Afterwards, all the necessary data 
were deleted permanently from all devices (e.g. 
researcher’s laptop, flash drive, and all possible 
devices). The implementation of these actions will 
lessen the risk of data leakage and will protect the 
reputation of the hospital.  
● In response to the 12th principle under “General 
Principles,” the research was conducted by medical 
technology students from University of Santo Tomas 
Faculty of Pharmacy and is supervised by their thesis 
adviser. 
Risks: 
Risk is characterized as the likelihood of harm as a result of 
involvement in a research study, whether it is physical, 
psychological, social, legal, or in economics (Human Subjects 
Protection Program Policy Manual, 2021). In conducting 
research, some risks can be encountered. The possible risk that 
may be encountered as well as their corresponding mitigation 
measures are shown in the table below. 
 











data to other 
institutions or 
individuals 
If the data will be given digitally, only 
one email address will be given to the 
hospital where they will send the data. 
The researchers should ensure that the 
given email address is active and 
correctly inputted to avoid falsely 
sending the data to other emails. Prior to 
access, the statistician must first sign an 
agreement form in regards to the 







If no classification was done by the 
hospital, the researchers will request for 
the medical records of the patients to 
classify them in terms of COVID-19 
severity. 
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lacking of data 
for mild 
patients in the 
chosen 
hospital 
The researchers will settle with the 
procured data. The parameters are not 
usually affected and are expected to be 
in normal range so they are not being 
tested on mild patients. 
 
Benefits: 
There are no direct benefits to participants. According to Luna-
Lucero (2018) benefit does not require to be directed to 
participants of the study, as it may provide benefit to the public 
or in the research field.  
Moreover, the results of this study may further improve the 
understanding about COVID-19 infection. Lastly, the hospital 
that gave the data will have access to the results of the study 
once the study is finished. 
Incentives or Compensation: 
No incentives or compensation will be provided as the study 
only makes use of secondary data and thus, has no study 
participants nor contact with the patients where the data 
originated from. 
Conflict of Interest: 
The researchers declare no conflict of interest in preparing this 
study. As stated by the University of Queensland (2020), 
conflict of interest arises when individuals differ from his or her 
own interest, and obligations over the given duties and 
responsibilities needed to adhere as a researcher.  
This study is to be conducted independently in a form of 
educational requirement in the academe undertaken by BS 
Medical Technology students. Therefore, the study will not 
receive specific grants from any organization in the public, 
commercial, or profit sectors. 
Data Analysis: 
Firstly, to accomplish the first objective, the data, which 
includes the laboratory values and the severity of infection, was 
outlined through descriptive statistics. Descriptive statistics 
was used for the simple description and comprehension of the 
details of a specific data set by giving a summary of the data. 
This is usually applied to rearrange large quantitative data into 
short and understandable descriptions (Kenton, 2019). 
 
The fulfillment of the second objective was done by calculating 
the measure of central tendency such as the mean; and measure 
of variability such as the standard deviation will be used. In 
order to summarize the obtained data from the chosen hospital, 
the use of central tendency will determine the center of the 
distribution and provide a probability distribution value to 
describe the set of data. Mean is used as the average value of 
the set of data (La Trobe University, 2020). Furthermore, this 
study made use of measures of variability to provide descriptive 
information about the distribution of variables within the data. 
Standard deviation was utilized to measure the average distance 
between the values of the data in the set and the mean (La Trobe 
University, 2020). The laboratory parameters that have 
indefinite results were sorted categorically and be interpreted 
using the frequency count and percentage. The frequency count 
determines the number of times a variable occurs (Stephanie, 
2019). Moreover, the independent variables such as the 
laboratory results were subsequently interpreted through the 
use of the mean and standard deviation. Percentage, on the other 
hand, shows the prevalence of a certain category. Eventually, 
the overall data were presented visually using graphs and 
charts. 
 
After establishing the overview of the data, to carry out the last 
objective, the data were analyzed with the use of a higher 
statistical analysis tool, which is logistic regression. This 
particular statistical treatment associates the binary dependent 
variable and a set of independent variables (Swaminathan, 
2018). In this study, the categorical dependent variable, also 
called as the response variable, is the severity of infection (i.e., 
mild and severe); and the set of independent variables are the 
selected laboratory values. The dependent variables are 
dichotomous wherein the mild case is classified as “0” and the 
severe case is classified as “1”. Through this analysis, each 
laboratory value will form a tool used to establish the likelihood 
of severe COVID-19 infection. Logistic Regression measures 
how the dependent variable is correlated with the independent 
variable (Sarstedt and Mooi, 2014). Logistic regression has a 
fixed number of parameters that are dependent on the number 
of input variables or the categorical predictor (Hoffman, 2019). 
Furthermore, binary logistic regression can determine the 
impact of the variables - in this case, the laboratory values - to 
predict which category they are more likely to belong (Hua, et. 
al, 2021). This describes how significant laboratory values are 
numerically related to the severity of COVID-19 infection. In 
doing so, the concept of odds ratio is used. Odds ratio shows 
the constant effect of a predictor (independent variable) on the 
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likelihood that one outcome will occur (Martin, 2012). 
Ultimately, a set of laboratory values are established as a tool 
in predicting which has the most significant effect in the 
severity of the COVID-19 infection. 
IV. RESULTS AND DISCUSSION 
This chapter includes the presentation, analysis and 
interpretation of the data. It tackles the prevalence of the 
COVID-19 cases by severity through the usage of percentage. 
Moreover, the characteristics of the patients in terms of their 
laboratory test results are also shown. Mean and standard 
deviation, as well as median and IQR, were computed. Lastly, 
the estimated logistic regression models are also discussed 
which presents the individual laboratory parameters in 
predicting the severity of COVID-19 infection. The results 
were generated from R software ver. 4.1.0 running on RStudio 
ver. 1.4.1717. 
A. Presentation and Analysis of Data 
Prevalence of COVID-19 Cases Classified as Mild and Severe: 
 
Fig.3. Distribution of COVID-19 Cases by Severity 
 
This figure presents the distribution of COVID-19 severity 
among the selected patients. Fifty-eight patients or about 51.3% 
of them had mild symptoms of COVID-19 while the remaining 
48.7% had experienced severe symptoms of COVID-19. 
According to this figure, there is a relatively high prevalence of 
severe COVID-19 patients when observed together with mild 
COVID-19 patients. 
 
Laboratory Values of Mild and Severe COVID-19 Cases: 
 
Table.3. Summary Statistics of Laboratory Results of the Selected 
Patients with Mild and Severe Case of COVID-19 
Mild Severe 











































  C-reactive 
protein     











  Lactate 
Dehydrogenase 









*Numbers inside the parentheses are computed standard deviations. ** 
Numbers inside the parentheses are interquartile ranges. 
 
The table above presents the summary statistics of the 
laboratory results of the selected patients with mild and severe 
symptoms of COVID-19. Based on the table above, the mean 
neutrophil count in mild cases is 0.60 with a standard deviation 
of 0.13. Its corresponding median is 0.59 which is not far from 
the computed mean value which suggests that the distribution 
of neutrophils is more or less symmetric across all patients with 
mild COVID-19 symptoms. On the other hand, the mean 
neutrophil count is 0.77 (SD = 0.14) and the median is about 
0.81 for patients with severe COVID-19 symptoms. It also 
suggests that the mean and median neutrophil count of patients 
with severe symptoms of COVID-19 is higher than those with 
mild symptoms of COVID-19.  
 
In patients with mild cases, the mean and median values for 
lymphocytes are 0.30 and 0.31, respectively, with the standard 
deviation of 0.11. In patients with severe cases, however, the 
mean and median values for Lymphocytes are 0.17 (SD = 0.14) 
and 0.13, respectively. This suggests that the mean and median 
lymphocyte count of patients with severe cases of COVID-19 
is lower than normal compared to those with mild cases of 
COVID-19.  
 
Meanwhile, the mean ALT for patients with mild cases is 43.94 
with the standard deviation of 41.80. Its mean is about 19 units 
higher than the median indicating that its distribution is skewed 
to the right. On the other hand, for patients with severe cases, 
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the mean and median values for ALT are 89.45 (SD = 84.74) 
and 71.5, respectively.  
Next, the mean CRP for patients with mild cases is 6.27 (SD = 
16.21) which is about 5 times greater than the median value. 
This suggests that its distribution is highly skewed to the right. 
For patients with severe cases, however, the mean and median 
values for CRP are 78.58 (SD = 91.69) and 44.285, 
respectively.   
Lasty, for patients with mild cases, the mean LDH is 186.63 
(SD = 42.93) which is 80 times greater than its median value. 
Although for patients with severe cases, the mean LDH is 
437.81 (SD = 232.26) and the median is about 409. This means 
that the distribution of LDH is skewed to the right. This 
suggests that the mean and median ALT, CRP, and LDH of 
patients with severe symptoms of COVID-19 are higher than 
those of patients with mild cases. 
With the aid of the logistic curve generated through the 
logistical regression model, the data dispersion between the 
mild and severe cases was shown. The predicted probabilities 
of having severe COVID-19 infection were plotted using a 
logistic curve, as shown by the red line that lies across the 
independent variable's ranges of values. Moreover, the 
relationship between the independent and outcome variable was 
determined by the slope of the curve. Therefore, in a positive 
slope, the probability of having severe COVID-19 increases 
when the value of the independent variable also increases. 
Conversely, in a negative slope (inverted S), the probability of 
having severe COVID-19 decreases when the value of the 
independent variable increases. 
The y-axis depicts the severity of infection where a value that 
falls in line “0” is considered a “mild case” and a value that falls 
in line with “1” is considered a “severe case”. Meanwhile, the 
x-axis represents the level of the laboratory values. 
 
Fig.4. Logistic Curve of Neutrophils 
Neutrophil count has a reference range that is from 0.55 to 0.70 
U/L. As seen in Figure 4, the logistic curve proves the existence 
of mild and severe cases in all low, normal, and high levels. 
From this, it is evident that the data are widely distributed. 
 
Fig.5. Logistic Curve of Lymphocytes 
 
The logistic curve of lymphocytes is exhibited by Figure 5. The 
lymphocyte count has a reference range of 0.25 to 0.40 U/L. 
The figure indicates that in low and normal levels, both mild 
and severe cases occur. Hence, the data are distributed widely. 
 
Fig.6. Logistic Curve of ALT 
 
Displayed in Figure 6 is the logistic curve of ALT. ALT has a 
reference range of 14 to 54 U/L. This exhibits data that are 
widely distributed since the occurrence of both mild and severe 
cases appears in all low, normal, and high levels. In addition, 
the curve also presents the premise that any value greater than 
200 U/L will only result in a severe COVID-19 case. 
 
Fig.7. Logistic Curve of CRP 
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As for the logistic curve of CRP, it is shown in Figure 7 above. 
Moreover, the data for CRP are described to be widely 
distributed. This is because of its reference range which is from 
0 to 5 mg/L, expressing the existence of both mild and severe 
cases in both normal and high levels. Furthermore, this curve 
also reveals that any value greater than 100 mg/L will only 
result in a severe COVID-19 case. 
 
Fig.8. Logistic Curve of LDH 
 In Figure 8 shown above, the logistic curve of LDH is 
depicted. The reference range is found to be from 135 to 225 
U/L, which expresses that in all low, normal, and high levels, 
both mild and severe cases occur. From this, it is conclusive to 
say that the data are widely distributed. Additionally, the curve 
also suggests that any value greater than or equal to 400 U/L 
will only result in a severe COVID-19 case. 
 
Some variables, however, have values that are indefinite (eg. > 
1200) hence, computation of summary statistics does not apply 
to them. The researchers transformed these variables into 
categorical ones to analyze them using frequency and 
percentages. Note that the ranges were arbitrarily made only 
based on the empirical distribution of the variables. The ranges 
are selected such that each category or level has a sufficient 
element that can be used in further analyses. Furthermore, 
missing values are recorded into the No data category. The 
following table presents the result of the variable 
transformations. 
 
Table.4. Frequency Distribution of Laboratory Results of the Selected 
Patients with Mild and Severe Case of COVID-19 











  Ferritin 
(ng/mL) 
    
    Low 2 3.6% 1 1.8% 
    Normal 42 75% 5 9.1% 
    High 12 21.4% 49 89.1% 
  D-Dimer 
(ug/mL) 
    
    Normal 54 93.1% 23 41.8% 
    High 3 5.2% 28 50.9% 
    No data 1 1.7% 4 7.3% 
  Procalcitonin     
  (ng/mL) 
    
   Low 37 63.8% 41 74.5% 
   Normal 0 0% 8 14.5% 
   No data 21 36.2% 6 10.9% 
 
Table 4 presents the frequency distribution of the variables 
Ferritin, D-Dimer, and Procalcitonin levels. Based on the table, 
about 75% of patients with mild symptoms of COVID-19 have 
normal Ferritin levels; and about 89.1% of the patients with 
severe COVID-19 have high levels of Ferritin. Moreover, 54, 
or about 93.1% of the patients with mild COVID-19 have 
normal levels of D-dimer. In contrast, more than half of 
patients, about 50.9% of severed COVID-19 have elevated D-
dimer levels. Finally, no patient with mild symptoms of 
COVID-19 has a normal level of procalcitonin while a greater 
proportion of patients, about 74.5% with severe COVID-19 
have low levels of procalcitonin.  
 
Once again, with the aid of the logistic curve, the data 
dispersion between mild and severe cases were observed. 
 
 
Fig.9. Logistic Curve of Ferritin 
Demonstrated in Figure 9 is the logistic curve of ferritin. The 
reference range of ferritin is from 20 to 350 ng/mL. Based on 
this, both mild and severe cases exist in all low, normal, and 
high levels. Therefore, the data are described to be widely 
distributed. Aside from that, this curve also shows that any 
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value greater than approximately 1000 ng/mL will only result 
in a severe COVID-19 case. 
 
Fig.10. Logistic Curve of D-Dimer 
Figure 10 shows the logistic curve of D-dimer. The reference 
range for D-dimer is less than 0.5 ug/mL, which shows that in 
all low, normal, and high levels, severe cases exist. 
Additionally, majority of the mild cases had normal levels. 
Lastly, it can be seen that a value greater than 0.9 ng/mL will 
only result in a severe COVID-19 case. 
 
Fig.11. Logistic Curve of Procalcitonin 
Fig.11. shows the logistic curve of procalcitonin. The reference 
range for Procalcitonin is 0.5 to 2 ng/mL, which shows that in 
all low, normal, and high levels, severe cases exist. Moreover, 
it was also shown that mild cases will tend to have much lower 
value than severe cases since a value greater than 0.39 ng/mL 
will only result in a severe COVID-19 case. Additionally, all 
mild cases had low procalcitonin levels. 
 
Determining the Significant Predictors of COVID-19 Severity: 
 
This section will discuss the estimated logistic regression 
models to determine which laboratory results can be used to 
predict the severity of symptoms experienced by a COVID-19 
patient. The model with all the independent variables entered in 
the model is shown in the following table.  
 
Table.5. Summary of Odds Ratio Estimates from Logistic Regression 











Intercept 0.00 NA  0.999 
Neutrophils 0.92 0.00 9.72E+13 0.9943 
Lymphocytes 156.1
6 0.00 7.40E+19 0.7557 
Alanine 
aminotransferase 1.03 1.00 1.06 0.099 
C-reactive protein 1.01 0.99 1.05 0.5034 
Lactate 
Dehydrogenase 1.03 1.01 1.08 0.0902 
Ferritin (baseline: 
0 to 100)    
 
    101 to 500 0.05 0.00 1.02 0.1055 









(baseline: < 0.10)   
  

















(baseline: < 0.05)    
 
   0.05 to 0.50 5.98E
-18 0.00 0.00 0.9969 
   > 0.50 2.87E
-12 0.00  0.9986 
 
The table above presents the calculated odds ratio with their 
corresponding confidence intervals for the logistic regression 
model with all lab results as the independent variables in the 
model. As seen on the table, we can observe that there are 
absurd estimates such as very low values of odds ratio (e.g. 
5.98×10-18 or almost 0 for Procalcitonin: 0.05 to 50) and also 
some very high odds ratio (e.g. the estimates for Ferritin). Some 
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of the computed confidence intervals range from 0 to infinity 
which are too absurd and very uninformative. Upon 
investigation, these ridiculous values are primarily due to: 1) 
the independent variables are highly correlated in which the 
model has a problem of multicollinearity, and 2) there exists a 
quasi-complete separation in the data. Multicollinearity occurs 
when the independent variables of a linear model are highly 
correlated which inflates the standard error of the estimates and 
thus, gives us insignificant results and confidence intervals that 
are too wide. Meanwhile, quasi-complete separation exists 
when one cell of a given table has no element (existence of zero 
cells). This happens when one or more levels of the independent 
variable can determine the outcome variable with 100% 
certainty.  Due to these problems, the researchers will scrap the 
first model and try to create multiple simple logistic regression 
models using every independent variable. The results are shown 
in the following tables. 
 
Table.6. Summary of Odds Ratio Estimates from Logistic Regression 









Intercept 0.00255 0.00018 0.02434 < 0.0001** 
Neutrophil





**denotes significance at 1% alpha 
Table 6 gives us the summary of the logistic regression model 
with neutrophils as the predictor variable. Since the p-value of 
the estimated regression coefficient for neutrophil is less than 
0.0001 then the coefficient is deemed significant at a 1% 
significance level. Therefore, a 0.01-unit increase in the 
neutrophil count of the patient will increase their odds of having 
severe COVID-19 by a factor of 53.18. Hence, the risk of 
having severe COVID-19 increases as the level of neutrophils 
increases. 
 
Table.7. Summary of Odds Ratio Estimates from Logistic Regression 



















**denotes significance at 1% alpha 
Table 7 gives us the summary of the logistic regression model 
with lymphocytes as the predictor variable. Since the p-value of 
the estimated regression coefficient for lymphocytes is less than 
0.0001 then the coefficient is deemed significant at a 1% 
significance level. Therefore, a 0.1-unit increase in the 
lymphocyte count of the patient will decrease their odds of 
having severe COVID-19 by a factor of 0.000011. Hence, the 
risk of having severe COVID-19 decreases as the level of 
lymphocytes increases. 
 
Table.8. Summary of Odds Ratio Estimates from Logistic Regression 



















Table 8 gives us the summary of the logistic regression model 
with alanine aminotransferase as the predictor variable. Since 
the p-value of the estimated regression coefficient for alanine 
aminotransferase is less than 0.0024 which is less than 0.01, 
then the coefficient is deemed significant at a 1% significance 
level. Therefore, a 10-unit increase in the alanine 
aminotransferase of the patient will increase their odds of 
having severe COVID-19 by a factor of 10.2. Hence, the risk of 
having severe COVID-19 increases as the level of alanine 
aminotransferase increases. 
 
Table.9. Summary of Odds Ratio Estimates from Logistic Regression 
















protein 1.06 1.03 1.094 
< 
0.0001** 
**denotes significance at 1% alpha 
Table 9 gives us the summary of the logistic regression model 
with C-reactive protein as the predictor variable. Since the p-
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value of the estimated regression coefficient for C-reactive 
protein is less than 0.0001 then the coefficient is deemed 
significant at a 1% significance level. Therefore, a 10-unit 
increase in the C-reactive protein of the patient will increase 
their odds of having severe COVID-19 by a factor of 10.6. 
Hence, the risk of having severe COVID-19 increases as the 
level of C-reactive protein increases. 
 
Table.10. Summary of Odds Ratio Estimates from Logistic Regression 















se 1.029 1.019 1.042 
< 
0.0001** 
**denotes significance at 1% alpha 
Table 10 gives us the summary of the logistic regression model 
with lactate dehydrogenase as the predictor variable. Since the 
p-value of the estimated regression coefficient for lactate 
dehydrogenase is less than 0.0001 then the coefficient is 
deemed significant at a 1% significance level. Therefore, a 10-
unit increase in the lactate dehydrogenase of the patient will 
increase their odds of having severe COVID-19 by a factor of 
10.29. Hence, the risk of having severe COVID-19 increases as 
the level of lactate dehydrogenase increases. 
 
Table.11. Summary of Odds Ratio Estimates from Logistic Regression 









Intercept 0.1190 0.0411 0.2736 0.0030** 
Ferritin 
(normal)         
Low 4.2 0.1769 52.6078 0.274 
High 34.3 12.0707 117.1811 < 0.0001** 
**denotes significance at 1% alpha 
Table 11 gives us the summary of the logistic regression model 
with Ferritin as the predictor variable. Based on the table, there 
is no significant difference in the odds of having severe 
COVID-19 patients with low levels of ferritin compared to 
those with normal levels of ferritin (p-value = 0.274). On the 
other hand, there is a significant difference in the odds of having 
severe COVID-19 on patients with a high level of ferritin 
compared to those with normal levels of ferritin (p-value < 
0.0001). In particular, the odds of having severe COVID-19 of 
patients with high levels of Ferritin (> 350 mg/L) is 34.3 times 
higher compared to those with normal levels of ferritin. 
 
Table.12. Summary of Odds Ratio Estimates from Logistic Regression 









Intercept 0.4259 0.2566 0.6845 0.0006** 
D-Dimer 
(baseline: 
normal)         
High 







**denotes significance at 1% alpha 
Table 12 gives us the summary of the logistic regression model 
with D-dimer as the predictor variable. Based on the table, there 
is no significant difference in the odds of having severe 
COVID-19 of patients with no information on D-dimer 
compared to those with normal levels of D-dimer (p-value = 
0.0505). On the other hand, there is a significant difference in 
the odds of having severe COVID-19 on patients with elevated 
D-dimer compared to those with normal D-dimer (p-value < 
0.0001). In particular, the odds of having severe COVID-19 of 
patients with elevated D-dimer (> 0.5 ng/mL3) is 21.9 times 
higher compared to those with normal D-dimer.  
 
Table.13. Summary of Odds Ratio Estimates from Logistic 









Intercept 1.1081 0.7104 1.7343 0.6508 
Procalcitonin 
(baseline: 
low)         
   Normal 3839410
0 0 NA 0.990 
   No data 
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Table 10 shows the summary of the logistic regression model 
with the predictor variable Procalcitonin. The estimate for the 
odds ratio for the group with a normal level of procalcitonin 
level is too large due to the quasi-complete separation where all 
of the patients with normal procalcitonin levels have severe 
symptoms of COVID-19. Meanwhile, those patients with no 
information on procalcitonin levels have a significantly lower 
odds of having severe COVID-19. Particularly, the odds of 
having severe COVID-19 is 0.2578 times lower than patients 
with low levels of procalcitonin. Additionally, no data were 
found to be higher than the reference range. 
 
B.  Interpretation of Data 
 
Prevalence of COVID-19 Cases Classified as Mild and Severe: 
 
Differences between mild and severe may be attributed to race, 
gender, and age (Weill Cornell Medicine, 2020). Underlying 
medical conditions are not included since the researchers 
excluded patients with comorbidities. 
 
A study from the University of East Anglia asserted that 
patients with preexisting disease are at a higher risk to be 
infected by COVID-19.  This study was supported by an article 
written by Mayo Clinic (2021) which states that older patients 
with health problems like heart or lung conditions, diabetes, 
obesity, and weak immune system are at a greater risk to be 
infected by COVID-19 in contrast to younger and healthier 
patients. However, a study by Harvard Health Publishing 
(2021), stated that healthy patients can also get infected by 
COVID-19. Additionally, everyone in any age group was 
recommended to get vaccinated. This explains why out of the 
hundreds that are admitted in the chosen hospital, only 113 
patients (55 severe; 55 mild) matched the criteria for the study. 
This limited data are mostly due to the criteria ‘without 
comorbidities’. 
 
Laboratory Values of Mild and Severe COVID-19 Cases: 
 
Neutrophils: 
A study by Cavalcante-Silva et al. (2021) stated that neutrophils 
are the first responders in inflammatory reaction and 
additionally, the process of neutrophil activation and 
degranulation are highly activated in COVID-19 infection.  
Additionally, a study conducted by Reusch et al. (2021) 
demonstrated increased neutrophils in the nasopharyngeal 
epithelium and distal parts of the lung upon COVID-19 
infection. Since the body continues to respond to the COVID-
19 infection, Wang et al. (2020) posits that the neutrophils 
contribute to the frequent occurrence of cytokine storms in 
severe cases coinciding with lung injury attributed to COVID-
19, which explains why neutrophils are still elevated in severe 
cases. Lastly, Cavalcante-Silva et al. (2021) also said that 
although the neutrophils provide protection, prolonged 
activation can produce a harmful effect in the lungs and 
progress to pneumonia and/or acute respiratory distress 
syndrome (ARDS). Supported by the study of Reusch et al. 
(2021), the neutrophil defense mechanisms, when done 
excessively, can activate the endothelial cells and worsen the 
inflammatory circuit or actively damage endothelial tissue. 
 
The results of the study also showed that mild patients had 
normal neutrophil levels. This finding is supported by Mardani, 
et al. (2020) since their study also resulted in the same finding. 
Their team then concluded that SARS-CoV-2 does not affect 
the neutrophils in the initial phase of the disease albeit being 
the first responders in an inflammatory reaction. 
 
Lymphocytes: 
Zhao et al. (2020) attribute it to possibly being caused by 
necrosis or apoptosis of the lymphocyte due to viral infection 
and damage similar to the mechanism of action of SARS-CoV 
(2020). Others postulate the cause of the significant decrease in 
lymphocyte count in accordance with infection severity as a 
consequence of the immune suppressive environment that 
hypercytokinemia brings, causing the destruction of 
lymphocytes. Furthermore, their results show that lymphopenia 
can serve as a rapid tool to be able to quickly identify a severe 
COVID-19 case. This supports the idea that patients with mild 
COVID-19 cases have normal lymphocyte results since 
lymphopenia, or severe low lymphocyte count, is persistently 
seen in most cases of severe infection (Yang et al., 2020). 
 
ALT: 
The elevation of aminotransferases, which includes alanine 
aminotransferase (ALT), was noted to be the most common 
abnormality in liver enzymes of COVID-19 patients, exhibiting 
an increase of 1-2 times the upper limit of normal, according to 
a study conducted by Moon & Barritt (2021). Among the 
potential causes of the said elevation include direct liver injury, 
drug-induced liver injury, hepatic ischemia, muscle breakdown, 
congestive hepatopathy, and inflammatory responses. Hence, a 
value of 200 U/L or greater is often seen in severe cases. 
Meanwhile, another study by Cai et al. (2020) supported this by 
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stating that the SARS-CoV-2 virus binds to angiotensin-
converting enzyme 2 (ACE2) on cholangiocytes. This 
eventually results in cholangiocyte dysfunction, as well as 
systemic inflammation, which ultimately causes liver injury. 
Thus, an increase in ALT, which is the enzyme released into 
the blood during liver injury, is seen in severe cases with 
damage to the said organ. In another study by Wang et al. 
(2020), most COVID-19 patients with mild cases had normal 
ALT levels because they maintained normal liver function 
throughout the course of the disease. The mild cases were also 
identified to rarely have a case of fatty liver and any liver 




As a response to the occurrence of infection, inflammation, and 
tissues, the liver produces C-reactive protein (Sadeghi-Haddad-
Zavareh, e al., 2021). Furthermore, C-reactive protein is 
considered to be an acute phase reactant that is non-specific and 
is declared to be an indicator of COVID-19 infection severity 
by Stringer et al. (2021). In infections such as COVID-19, the 
production of C-reactive protein is associated with the rise in 
inflammatory cytokines (Ali, 2020). Moreover, an increase in 
C-reactive protein is also observed in pneumonia and lung 
infections which are commonly noted as clinical manifestations 
of COVID-19 infection. The said increase is mostly seen in 
severe cases since there is more damage in the lungs as caused 
by the infection (Wang, 2020). Another study by Bozkurt et al. 
(2021) posited that elevated C-reactive protein levels were 
found in COVID-19 cases that are severe rather than mild. 
Myocardial injury, higher troponin-T levels, and the 
development of ARDS attribute to the said finding since they 
are more correlated with severe cases. Thus, normal C-reactive 
protein levels were observed in mild cases. 
 
LDH: 
Lactate dehydrogenase (LDH) is an intracellular enzyme which 
catalyzes the interconversion of both pyruvate and lactate with 
NADH and NAD+. In a study conducted by Henry et.al. (2020), 
this enzyme is a biomarker of interest for COVID-19 prognosis 
as its increased levels have been linked with patients with 
severe respiratory viral infections such as the Severe Acute 
Respiratory Syndrome (SARS). Due to the presence of LDH in 
lung tissues, patients with severe COVID-19 infections exhibit 
interstitial pneumonia which releases high amounts of LDH 
into the circulation and could remain there up to 7 days. This is 
further supported by the study of Shi et.al. (2020) wherein their 
findings of increased LDH in early phases of severe COVID-
19 cases indicate possible subclinical tissue damage. 
Contrarily, mild cases are shown to have no sign of pneumonia 
on thoracic imaging (Xia, et.al., 2020). It was then concluded 
that elevated LDH values were associated with a sixfold-odds 
increase of severity in COVID-19 disease (Henry et.al., 2020). 
 
Ferritin: 
Ferritin is a significant intracellular iron storage protein. The 
study Carubbi et al. (2021) emphasizes that iron metabolism 
may boost the immune system's response to invading microbes, 
including viral infections, by increasing ferritin levels. For viral 
replication to occur, host cells must have an improved cellular 
metabolism and optimum iron levels. Thus, decreasing iron 
bioavailability is necessary for interfering with virus 
replication. In relation to this, according to Gómez-Pastora et 
al. (2020) in a systematic review on the use of ferritin in 
COVID-19. Ferritin values in COVID-19 patients were 
generally within the normal range in patients with the non-
severe condition. However, patients with severe COVID-19 
infection had hyperferritinemia. With this, a study by Liu et. al. 
(2019) reported that, when the health of the patients started to 
improve, their ferritin and IL-6 levels decreased. In addition, in 
severe COVID-19, ferritin has been identified as an acute phase 
reactant as well as a modulator of immunological 
dysregulation. Therefore, this could support the idea that 
hyperferritinemia is linked to inflammatory states in SARS-
CoV-2 infection, and that ferritin could be more than just a 
marker of the inflammatory environment; it could also be a key 




D-dimer is produced when fibrin from clots is broken down 
(Yao et al., 2020). Any process or disorder involving fibrin 
production or breakdown causes increase in D-dimer levels. 
Inflammation, specifically proinflammatory cytokines, cause 
an increase in D-dimer levels (Yu et al., 2020). Conversion of 
fibrinogen to fibrin, fibrin reticulation and fibrin degradation by 
plasmin all elevate D-dimer levels (Moreno et al., 2021). 
Disseminated Intravascular Coagulopathy (DIC) is a 
complication prominent in severe COVID-19 infections, along 
with hypercoagulability (Moreno et al., 2021), that can be 
caused by sepsis with intense inflammatory reaction among 
others (Levi, 2018). The mechanism is the activation of 
monocytes and endothelial cells which causes an uncontrolled 
release of cytokines (Moreno et al., 2021). The uncontrolled 
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release of proinflammatory cytokines as well as the endothelial 
damage and fibrinolysis induced by the infection cause the 
elevated D-dimer levels (Levi & Iba, 2020). Levi & Iba (2020) 
also found that while D-dimer levels displayed gradual 
elevation during the progression of the disease, a significant 
portion of the severe and a lesser still significant portion of the 
non severe cases showed D-dimer elevation. While the severe 
infection displayed extremely elevated values, cases of normal 
D-dimer values were also present with the severe infection. The 
elevated levels found in severe infections are attributed to the 
multiple possible coagulation related complications brought 
upon by the extended uncontrolled release of proinflammatory 
markers that cause accumulation of inflammatory cells as 
postulated by (Levi & Iba, 2020). 
 
Procalcitonin: 
Procalcitonin is usually produced during bacterial infection but 
some studies also suggest its relevance in COVID-19 infection, 
as mentioned by Hu et al. (2020). A high level of procalcitonin 
is usually seen in bacterial infections such in the case of 
bacterial pneumonia. On the other hand, viral infections, such 
as in the case of COVID-19 infections, procalcitonin level is 
low; this is the main reason why procalcitonin is seen low in 
both mild and severe COVID-19 infection (Schuetz, 2021). In 
severe COVID-19 infection, a slightly higher or within a 
normal reference range is seen due to the probable co-existence 
of a bacterial infection during the duration of COVID-19 
infection (Vanhomwegen et al., 2021).  
Lastly, a study conducted by Nasir et al. (2021) states that some 
hospitalized COVID-19 patients were infected with gram-
negative bacteria; however, the chances of coinfection with 
bacteria for hospitalized patients are still unknown. 
Furthermore, the said study also states that there is a very little 
to no difference between the levels of procalcitonin of patients 
with different COVID-19 severity infection; with the severe 
having a slightly higher result because they are more vulnerable 
to bacterial infection. This explains why there is a low level of 
procalcitonin in mild cases and a normal result in severe cases. 
 
 Determining the Significant Predictors of COVID-19 Severity: 
 
Neutrophils: 
As the COVID-19 infection progresses into a severe case, the 
neutrophil count in the bloodstream also increases. With this, 
elevated neutrophil levels can be used to predict the severity of 
infection. Neutrophil Extracellular Traps (NETs), which are 
produced by the neutrophils, control the infection. These NETs, 
in turn, exacerbate inflammation. Increased production of 
NETs also contributes to the venous and arterial thrombosis in 
COVID-19 patients. This finding shows that NETs can trigger 
cytokine release and multi-organ damage that leads to 
respiratory failure and coagulopathy. Moreover, high levels of 
chemokine ligands in COVID-19 patients can lead to the 
recruitment of more neutrophils to the site of infection, which 
further aggravates the pulmonary inflammatory response. 
(Wang et al, 2020) 
 
Lymphocytes: 
Lymphocytes are affected by both the viral mechanism and 
hypercytokinemia as suggested by both Wagner et al. (2020), 
and Zhao et al. (2020). The decline in lymphocyte count is 
associated with lymphocyte exhaustion due to extended or 
prolonged stimulation and stress from hypercytokinemia (Fathi 
& Rezaei, 2020); moreover, lymphocytes produced during 
lymphocyte exhaustion also have impaired functionality (Fathi 
& Rezaei, 2020). 
 
ALT: 
Alanine aminotransferase (ALT) is a liver enzyme that is 
released in the bloodstream when the liver is afflicted by 
damage. In a research conducted by Ampuero et al. (2020), 
COVID-19 patients who have liver injury were recorded to 
have notably higher risk of further developing severe cases as 
opposed to patients whose liver function tests presented normal 
results.  
As supported by the studies mentioned earlier, ALT exhibits a 
directly proportional relationship with COVID-19 severity due 
to the fact that the virus, SARS-CoV-2, binds to angiotensin-
converting enzyme 2 (ACE2) on cholangiocytes, causing its 
dysfunction which leads to liver injury. Aside from that, 
increased ALT levels and intensified severity may also be 
caused by other factors such as hepatic ischemia, muscle 
breakdown, and congestive hepatopathy among others. 
 
CRP: 
C-reactive protein level greater than 100 mg/L is usually 
manifested in severe cases of COVID-19 due to tissue 
destruction caused by the hyperactivity of the immune system 
(Wang, 2020).  
The elevation of CRP is related to the production of cytokines 
which are usually observed in patients with COVID-19. The 
destruction of tissues caused by the viral infection is the main 
reason for the increase in CRP (Ali, 2020). 
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From the study of Aggarwal et. al. (2020), elevated LDH levels 
in COVID-19 patients indicate high severity of the infection. 
As mentioned previously, this is due to the interstitial 
pneumonia caused by the disease in which the present LDH-3 
in the pneumocytes is inherently released into the bloodstream. 
From the pooled analysis in the said study, elevated LDH 
values are commonly associated with a sixfold increased odds 
of getting a severe COVID-19 disease. This indicates that the 
severity of the disease is directly proportional to the increase 




The study of Habib et al. (2021) indicated that 
Hyperferritinemia (condition in which ferritin levels are 
abnormally high) is commonly used as a marker for the 
“hyperferritinemic syndromes” linked to severe COVID-19 
infection. COVID-19 systemic inflammatory reaction and 
“hyperferritinemic syndromes” cause symptoms such as 
elevated serum ferritin and sustained cytokine storm-generated 
hyper-inflammation which brings about multiorgan failure. 
Furthermore, since Ferritin is an iron-storing protein, the free 
iron released into the bloodstream may cause iron overload, 
resulting in damage to the lungs and other organs. It's also been 
suggested that the COVID-19 virus has hepcidin-mimicking 
properties, which could lead to an increase in ferritin levels 




As stated earlier D-dimer is a byproduct of fibrin breakdown. 
The increase in D-dimer levels may be attributed to the 
uncontrolled inflammatory response of the body causing 
elevated prothrombotic activity, endothelial injury, and 
coagulation (Yu et al., 2020). According to Zhou et al. (2020), 
elevated D-Dimer levels (> 1 μg/ml) are related to the deadly 
COVID-19 infection outcome.  While others refute it, a study 
by Ye et al. (2020) indicated that patients with COVID-19 
infection with an increased D-dimer levels (>2.14 mg/L) on 
hospital admission may be at higher risk of in-hospital mortality 
(Ye et al., 2020), which supports the findings of D-dimer levels 
reaching up to 8 times the ULN in severe cases. 
 
Procalcitonin: 
According to the study conducted by Hu et al. in 2020, 
procalcitonin is seen elevated in COVID-19 infections. In 
severe cases it can be as high as 4 times from the normal range; 
additionally, it is lower in patients with mild COVID-19 cases. 
Furthermore, Schuetz (2020) also claimed that severe COVID-
19 patients have an elevated level of procalcitonin due to 
development of inflammatory syndrome like pneumonitis 
during the course of COVID-19 infection. 
V. CONCLUSION 
The following chapter discusses a brief summary and 
interpretation of the data gathered from the previous chapter, 
along with the conclusions of significance derived with logistic 
regression model from the laboratory parameters on severity. 
Following are the recommendations for further study that the 
proponents came up with to compensate for any inadequacies 
or deficiencies in the current study. 
 
A. Summary of Findings 
 
The prevalence of COVID-19 cases was determined with the 
use of descriptive statistics, frequency and percentage on the 
mild and severe cases. The data set collected displayed a 
relatively similar distribution of 48.7% or 55 severe COVID-19 
patients in comparison to the 51.3% or 58 mild COVID-19 
patients. 
 
The results gathered from the laboratory test results of selected 
patients with mild and severe cases of COVID-19 infection 
were measured and analyzed using descriptive statistics. 
Evidently, patients with severe COVID-19 symptoms have 
greater mean and median neutrophil counts, ALT, CRP, and 
LDH levels than patients with mild COVID-19 symptoms. 
Patients with mild COVID-19 symptoms, on the other hand, 
had a greater mean and median lymphocyte count than those 
with severe COVID-19 symptoms. For Ferritin, D-Dimer, and 
PCT, since some variables have indefinite values, the variables 
for each respective laboratory parameter were analyzed 
categorically. The results showed that 75% of COVID-19 
patients with mild symptoms have normal Ferritin levels, and 
89.1% of COVID-19 patients with severe symptoms have high 
Ferritin levels. Furthermore, 93.1% of patients with mild 
COVID-19 have normal D-dimer values. Those with severed 
COVID-19, on the other hand, have increased D-dimer levels 
in more than half of the cases with the percentage of 50.9%. 
Finally, no patient with mild COVID-19 symptoms has a 
normal PCT level, whereas 74.5% of patients with severe 
COVID-19 symptoms have low PCT levels. 
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By utilizing the logistic regression as the statistical model, it 
was shown that multiple simple logistic regression produces a 
better result where each independent variable was individually 
analyzed. Among the eight available independent variables, 
seven were found to be significant predictors. Including the 
insignificant predictors, the predictors will be categorized into: 





Neutrophil, ALT, CRP, and LDH were found to be significant 
predictors, which are directly proportional. This means that as 
their level increases, the odds of having a severe case also 
increases. 
 
Lymphocyte was also found to be a significant predictor but it 
has an inversely proportional relationship with the severity of 
infection. This means that as the level of lymphocytes 
decreases, the odds of having a severe case increase. 
 
Significant at a High Level: 
 
Ferritin and D-dimer were also found to be significant, 
however, only at high levels since high levels of these 
predictors tend to result in a severe case. On the other hand, the 
low and normal levels of these predictors will result in both 




Procalcitonin was found to be insignificant. This is due to the 
fact that all patients with normal procalcitonin are severe cases; 
and all mild patients have low procalcitonin. Additionally, the 
majority of the severe cases also had low procalcitonin. This 





With respect to the generated outcome of results, the 
researchers arrived at the conclusion of accepting the 
alternative hypothesis and rejecting the null hypothesis; seven 
of the laboratory values namely neutrophils, lymphocytes, 
ALT, CRP, LDH, ferritin, and D-dimer, were significant 




From this thesis, the researchers would also like to propose that 
medical professionals should focus on monitoring neutrophils, 
ALT, CRP, LDH, ferritin, and D-dimer since the increase of 
these parameters can be indicative of severe COVID-19 
infection. Low levels of lymphocytes, on the other hand, are 
associated with severe cases. 
 
● These laboratory values can be used as an early 
measure before symptoms set in to determine 
treatment and application of medication to mitigate 
adverse symptoms and complications associated with 
severe COVID-19 infection. 
● Since there is a possibility that these markers are 
increased due to the body’s protective responses, a 
recommended alternative or supportive treatment 
could be to strengthen or control the production of 
these increased biomarkers. 
● Treatments such as increasing the lymphocyte level 
back to normal can also be given to patients. 
Contrarily, administering treatments that further 
suppress lymphocyte production may threaten the 
patient’s life. 
 
There are also some recommendations to future researchers 
who will be writing similar studies: 
 
● Use a wider set of laboratory parameters in analyzing 
the severity of COVID-19 infection.  
● Include the moderate and critical classifications to be 
able to analyze the complete scope of the severity of 
COVID-19 infection and work with a larger set of 
population 
● Focus on the analysis of similar studies on a particular 
age group.  
● Include the patients with comorbidities to know how 
these affect the overall condition and classification of 
COVID-19 infection. 
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